Literature DB >> 1586611

Refusal in testicular cancer patients: implications for surveillance.

J W Moul.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1586611      PMCID： PMC1977384          DOI： 10.1038/bjc.1992.168

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  5 in total

1.  Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer.

Authors:  S D Williams; D M Stablein; L H Einhorn; F M Muggia; R B Weiss; J P Donohue; D F Paulson; K W Brunner; E M Jacobs; J T Spaulding
Journal:  N Engl J Med       Date:  1987-12-03       Impact factor: 91.245

2.  Refusal of cancer treatment in testicular cancer patients.

Authors:  J W Moul; D F Paulson; P J Walther
Journal:  J Natl Cancer Inst       Date:  1989-10-18       Impact factor: 13.506

3.  Testicular neoplasms in Hispanic brothers.

Authors:  C M Shapiro; N Otero; J Garcia; W J Yoon
Journal:  J Surg Oncol       Date:  1985-04       Impact factor: 3.454

4.  Treatment experience with nonseminomatous testicular cancer in patients with stage II and stage III disease.

Authors:  H G Taylor; A W Brown; W M Butler; M D Weltz; J L Berenberg; D G McCleod; J E Fowler; R E Stutzman; J Blom
Journal:  Cancer       Date:  1981-09-01       Impact factor: 6.860

5.  Compliance with follow-up of patients treated for non-seminomatous testicular cancer.

Authors:  B J Young; B D Bultz; J A Russell; M S Trew
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640
  5 in total
  1 in total

1.  Prospective study of factors predicting adherence to medical advice in men with testicular cancer.

Authors:  Clare Moynihan; Andy R Norman; Yolanda Barbachano; Louise Burchell; Robert Huddart; David P Dearnaley; Alan Horwich
Journal:  J Clin Oncol       Date:  2009-03-23       Impact factor: 44.544
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.